These emerging therapies, including Rybelsus, belong to a group of drugs called GLP-1 agents. Originally developed for controlling diabetes mellitus , they work by helping the pancreas to release adequate insulin and reducing increased glucose levels. Furthermore , their potential to promote slimming has resulted to substantial discussion and co… Read More